Back
Achieve Life Sciences Vs. Perspective Therapeutics Industry Stock Comparison
Buy
54
ACHV
Achieve Life Sciences
Last Price:
4.99
Seasonality Move:
1.15%
Buy
52
CATX
Perspective Therapeutics
Last Price:
1.60
Seasonality Move:
2.9%
Buy
54
Achieve Life Sciences (ACHV)
is a Buy
Is Achieve Life Sciences a Buy, Sell or Hold?
- The current Achieve Life Sciences [ACHV] share price is $5.00. The Score for ACHV is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- ACHV is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
52
Perspective Therapeutics (CATX)
is a Buy
Is Perspective Therapeutics a Buy, Sell or Hold?
- The current Perspective Therapeutics [CATX] share price is $1.60. The Score for CATX is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
- CATX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ACHV Stock Price Chart
What is Achieve Life Sciences's stock price today?
-
The Achieve Life Sciences share price today is $5.00
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ACHV is experiencing slight buying pressure.
CATX Stock Price Chart
What is Perspective Therapeutics's stock price today?
-
The Perspective Therapeutics share price today is $1.60
The current trend is moderately bearish and CATX is experiencing slight buying pressure.
ACHV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.14 | Buy |
| Relative Strength Index (14 RSI): | 60.24 | Buy |
| Chaikin Money Flow: | 6398 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.44 - 4.86) | Buy |
| Bollinger Bands (100): | (4.21 - 4.75) | Buy |
CATX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.05 | Buy |
| Relative Strength Index (14 RSI): | 49.16 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.53 - 1.77) | Sell |
| Bollinger Bands (100): | (0.67 - 1.53) | Buy |
ACHV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.87 | Buy |
| 20-day SMA: | 4.69 | Buy |
| 50-day SMA: | 4.58 | Buy |
| 200-day SMA: | 4.53 | Buy |
| 8-day EMA: | 4.92 | Buy |
| 20-day EMA: | 4.75 | Buy |
| 50-day EMA: | 4.61 | Buy |
| 200-day EMA: | 4.67 | Buy |
CATX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.69 | Sell |
| 20-day SMA: | 1.69 | Sell |
| 50-day SMA: | 1.47 | Buy |
| 200-day SMA: | 0.71 | Buy |
| 8-day EMA: | 1.66 | Sell |
| 20-day EMA: | 1.65 | Sell |
| 50-day EMA: | 1.46 | Buy |
| 200-day EMA: | 0.91 | Buy |
Achieve Life Sciences Earnings Growth & ACHV Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.13 per share, an increase this year of $0.42 per share, and an increase next year of $0.16 per share.
Perspective Therapeutics Earnings Growth & CATX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Achieve Life Sciences Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Perspective Therapeutics Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||